Jean J. M. C. H. Rosette (ed.); Michael J. Manyak (ed.); Mukesh G. Harisinghani (ed.); Hessel Wijkstra (ed.) Springer (2014) Saatavuus: Tilaustuote Pehmeäkantinen kirja
Simron Jit Singh (ed.); Helmut Haberl (ed.); Marian Chertow (ed.); Michael Mirtl (ed.); Martin Schmid (ed.) Springer (2014) Saatavuus: Tilaustuote Pehmeäkantinen kirja
Jean J. M. C. H. Rosette (ed.); Michael J. Manyak (ed.); Mukesh G. Harisinghani (ed.); Hessel Wijkstra (ed.) Springer (2009) Saatavuus: Tilaustuote Kovakantinen kirja
Michael Waters (ed.); Stephen Nesnow (ed.); Joellen L. Huisingh (ed.); Shahbeg S. Sandhu (ed.); Larry Claxton (ed.) Springer (1981) Saatavuus: Painos loppu Kovakantinen kirja
Michael Waters (ed.); Stephen Nesnow (ed.); Joellen L. Huisingh (ed.); Shahbeg S. Sandhu (ed.); Larry Claxton (ed.) Springer (2012) Saatavuus: Tilaustuote Pehmeäkantinen kirja
Springer Sivumäärä: 277 sivua Asu: Pehmeäkantinen kirja Julkaisuvuosi: 2011, 18.10.2011 (lisätietoa) Kieli: Englanti
Psychopharmacology of the Developmental Disabilities explores the use of psychotropic and antiepileptic medications in developmentally disabled patients. A distinguished group of international experts offers comprehensive coverage of traditional psychotropic as well as novel pharmacological agents, antiepileptic drugs, and diet and vitamin treatments. Issues related to litigation, measurement of blood levels, tardive dyskinesia, and behavioral pharmacology are discussed in detail. Psychopharmacology of the Developmental Disabilities provides an excellent overview of what is known about psychoactive drugs and an awareness of the principal social and medical issues posed by these agents.
